JENNIFER MARKLEVITZ: Open Payments
NPI 1750923843 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $66 |
| Janssen Pharmaceuticals, Inc | 2 | $53 |
| Lilly USA, LLC | 3 | $49 |
| Novo Nordisk Inc | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Amgen Inc. | 1 | $15 |
Products named: SPRAVATO, Rybelsus, AIRSUPRA, MOUNJARO, AJOVY, QULIPTA, Veozah, UBRELVY.
Industry payments across MI — which companies pay providers there.
